secwatch / observer
8-K filed May 16, 2024, 7:59 PM ET ticker XRN CIK 0001533615
other confidence high sentiment neutral materiality 0.35

Global Medical REIT shareholders approve 1.5M share increase to equity incentive plan at 2024 annual meeting

Chiron Real Estate Inc.

item 5.02item 5.07item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001104659-24-062602
form_type
8-K
ticker
XRN
cik
0001533615
company_name
Chiron Real Estate Inc.
filed_at
2024-05-16T23:59:59+00:00
discovered_at
2026-05-14T18:03:18.873918+00:00
generated_at
2026-06-01T21:01:22.944795+00:00
sec_items
["5.02", "5.07", "9.01"]
event_type
other
sentiment
neutral
materiality_score
0.35
calibrated_materiality_score
0.35
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001104659-24-062602
json_url
https://secwatch.observer/filing/0001104659-24-062602.json
markdown_url
https://secwatch.observer/filing/0001104659-24-062602.md
text_url
https://secwatch.observer/filing/0001104659-24-062602.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1533615/000110465924062602/0001104659-24-062602-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1533615/000110465924062602/tm2414756d1_8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

091f844ce0208bc64599bc2e885873faf618cd5e

Chiron Real Estate Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2024-05-15 meeting.

Proposal 5 — Ratification of Appointment of Independent Registered Public Accounting Firm: For Against Abstain Broker Non-Votes 48,840,222 608,585 122,277 0

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

6988e6c0314a32514e0d0aa88bcd8b2efd8a43e9

Chiron Real Estate Inc. shareholders approved Advisory Vote on the Frequency of Future Advisory Votes on Named Executive Officer Compensation at the 2024-05-15 meeting.

Proposal 3 — Advisory Vote on the Frequency of Future Advisory Votes on Named Executive Officer Compensation: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 34,040,745 158,991 1,098,203 566,323 13,706,822

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

7e82eb7714b53cd18cee63492b03f3fbb7808668

Chiron Real Estate Inc. shareholders approved Advisory Vote on Named Executive Officer Compensation at the 2024-05-15 meeting.

Proposal 2 — Advisory Vote on Named Executive Officer Compensation: For Against Abstain Broker Non-Votes 33,764,849 1,467,056 632,359 13,706,820

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

bb9a92edad55f18631fc2e7bfff2df1b1e30bc1c

Chiron Real Estate Inc. shareholders approved Election of Directors at the 2024-05-15 meeting.

Proposal 1 — Election of Directors: Nominee for Director For Against Abstain Broker Non-Votes Jeffrey M. Busch 33,520,679 2,266,304 77,283 13,706,818 Matthew Cypher 34,365,340 1,417,356 81,570 13,706,818 Ronald Marston 34,271,830 1,506,912 85,523 13,706,819 Henry E. Cole 35,307,015 471,399 85,852 13,706,818 Zhang Huiqi 35,307,700 463,912 92,658 13,706,814 Paula R. Crowley 35,321,456 459,003 83,810 13,706,815 Lori Wittman 34,362,196 1,408,313 93,758 13,706,817

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

dae85d31f1041ca51aa50e8e5da19740d0cfa66c

Chiron Real Estate Inc. shareholders approved Amendment to the Company’s 2016 Equity Incentive Plan to Increase the Number of Shares Reserved for Issuance Thereunder by 1,500,000 Shares at the 2024-05-15 meeting.

Proposal 4 — Amendment to the Company’s 2016 Equity Incentive Plan to Increase the Number of Shares Reserved for Issuance Thereunder by 1,500,000 Shares: For Against Abstain Broker Non-Votes 32,867,468 2,683,711 313,085 13,706,820

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

Comparable filings

HOST HOTELS & RESORTS L.P.

Host Hotels shareholders approve 2024 incentive plan, elect 9 directors at annual meeting

HOST HOTELS & RESORTS L.P. May 17, 2024, 7:59 PM ET other Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other similar materiality

This filing

Proposal 5 — Ratification of Appointment of Independent Registered Public Accounting Firm: For Against Abstain Broker Non-Votes 48,840,222 608,585 122,277 0

Comparable filing

Proposal 1 – Election of Directors Final votes regarding the election of nine directors for terms expiring at the 2025 annual meeting of stockholders are set forth below. Accordingly, each director nominee was elected for a one-year term.

Filing page SEC filing

CWK

Shareholders approve amended equity incentive plans at annual meeting

Cushman & Wakefield Ltd. May 17, 2024, 7:59 PM ET other Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other similar materiality

This filing

Proposal 5 — Ratification of Appointment of Independent Registered Public Accounting Firm: For Against Abstain Broker Non-Votes 48,840,222 608,585 122,277 0

Comparable filing

To approve an amendment to the Company’s Omnibus Non-Employee Director Share and Cash Incentive Plan, which was included as Annex D to the Proxy Statement. 185,554,595 2,674,219 9,435,353 13,258,886

Filing page SEC filing

PRTA

Prothena shareholders approve 2M share increase under LTIP at AGM

PROTHENA CORP PUBLIC LTD CO May 17, 2024, 7:59 PM ET other Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other similar materiality

This filing

Proposal 5 — Ratification of Appointment of Independent Registered Public Accounting Firm: For Against Abstain Broker Non-Votes 48,840,222 608,585 122,277 0

Comparable filing

The shareholders approved, in a non-binding advisory vote, the compensation of the Company’s executive officers named in the Proxy Statement. For Against Abstain Broker Non-Votes 45,331,500 425,331 1,194,023 2,591,833

Filing page SEC filing

CBAN

Colony Bankcorp: director Jonathan Ross retires at annual meeting; all board nominees elected

COLONY BANKCORP INC May 20, 2024, 7:59 PM ET other Items 5.02, 5.07

same fact type: shareholder_vote same SEC item: 5.02, 5.07 same event type: other similar materiality

This filing

Proposal 5 — Ratification of Appointment of Independent Registered Public Accounting Firm: For Against Abstain Broker Non-Votes 48,840,222 608,585 122,277 0

Comparable filing

On May 16, 2024, the Company held its Annual Meeting. As of March 22, 2024, the record date for the Annual Meeting, 17,558,611 shares of the Company's common stock were outstanding and entitled to vote at the Annual Meeting. A total of 13,876,693 shares, or 79.03% of Colony's common stock, constituting a quorum, were represented in person or by proxy at the Annual Meeting. The Company's shareholders voted on three proposals at the Annual Meeting. The final results of the votes, including the votes cast for, against or withheld, as well as the number of abstentions and broker non-votes, relating to each matter are as follows: Proposal 1. The election of eight directors to constitute the Company's Board of Directors to serve until the 2025 annual meeting of shareholders and until their successors are elected and qualified: Votes For Votes Withheld Broker Non-Vote Scott L. Downing 11,387,912 210,770 2,278,011 T. Heath Fountain 11,360,505 238,177 2,278,011 Audrey D. Hollingsworth 11,478,46

Filing page SEC filing

M

Macy's shareholders approve 2024 equity plan and re-elect all 15 directors at annual meeting

Macy's, Inc. May 20, 2024, 7:59 PM ET other Items 5.02, 5.07

same fact type: shareholder_vote same SEC item: 5.02, 5.07 same event type: other similar materiality

This filing

Proposal 5 — Ratification of Appointment of Independent Registered Public Accounting Firm: For Against Abstain Broker Non-Votes 48,840,222 608,585 122,277 0

Comparable filing

Shareholders approved the Macy’s, Inc. 2024 Equity and Incentive Compensation Plan, as follows: FOR AGAINST ABSTAIN BROKER NON-VOTE 174,055,063 23,906,158 637,516 27,583,104

Filing page SEC filing

CTMX

Stockholders approve doubling authorized common stock to 300M shares

CytomX Therapeutics, Inc. May 17, 2024, 7:59 PM ET other Items 5.03, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other similar materiality

This filing

Proposal 5 — Ratification of Appointment of Independent Registered Public Accounting Firm: For Against Abstain Broker Non-Votes 48,840,222 608,585 122,277 0

Comparable filing

Proposal 4. The Company’s stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement, pursuant to the compensation disclosure rules of the SEC. FOR AGAINST ABSTAIN BROKER NON-VOTES 27,396,411 1,905,835 61,704 17,554,723

Filing page SEC filing

BlackRock Finance, Inc.

BlackRock shareholders approve 7M share increase in stock plan, reject all three shareholder proposals

BlackRock Finance, Inc. May 17, 2024, 7:59 PM ET other Items 5.02, 5.07

same fact type: shareholder_vote same SEC item: 5.02, 5.07 same event type: other similar materiality

This filing

Proposal 5 — Ratification of Appointment of Independent Registered Public Accounting Firm: For Against Abstain Broker Non-Votes 48,840,222 608,585 122,277 0

Comparable filing

Item 3 – Approval of the Restated Plan: For Against Abstentions Broker Non-Votes 119,449,413 2,504,201 115,996 9,821,539

Filing page SEC filing

BMRC

Bank of Marin shareholders elect all 10 directors, approve say-on-pay, ratify auditor

Bank of Marin Bancorp June 1, 2026, 5:11 PM ET other Items 5.07, 8.01

same fact type: shareholder_vote same SEC item: 5.07 same event type: other similar materiality

This filing

Proposal 5 — Ratification of Appointment of Independent Registered Public Accounting Firm: For Against Abstain Broker Non-Votes 48,840,222 608,585 122,277 0

Comparable filing

To elect ten members of the Board of Directors to serve until the next Annual Meeting of Shareholders or until their successors are duly elected and qualified. Number of Votes For Withheld Non-Vote Nicolas C. Anderson 10,405,859 784,544 1,932,287 Russell A. Colombo 7,509,925 3,680,478 1,932,287 Charles D. Fite 10,810,421 379,982 1,932,287 Cigdem F. Gencer 10,818,514 371,888 1,932,287 James C. Hale 10,912,128 278,274 1,932,287 Kevin R. Kennedy 10,974,404 215,998 1,932,287 Timothy D. Myers 10,691,557 498,846 1,932,287 Joel Sklar, MD 10,985,406 204,997 1,932,287 Brian M. Sobel 10,859,501 330,902 1,932,287 Secil T. Watson 10,256,810 933,593 1,932,287

Filing page SEC filing

Source: SEC EDGAR
accession 0001104659-24-062602
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.